Commercial intelligence for bio-pharma
PharmSight sits between the evidence and the call. Analytics, real-world evidence, competitive intelligence, and forecasting, read together so a team can act.
The pressure
These are the gaps PharmSight is hired to close. They are commercial, not a copy of a manufacturing quality suite.
Sales and marketing numbers land in separate files. The story of what to do next is still assembled by hand.
A value story is asked for before the budget impact, outcomes, and dossier are in one place.
Pipeline moves, analyst notes, and conference signals arrive late, or not as one view.
In-line, pipeline, valuation, and supply models disagree because they were built apart.
How it works
Choose a source or an outcome. The center describes how PharmSight reads it, reasons with the therapy context, and recommends a next step. This is an explanation of the practice, not a live model.
Reads · Reasons · Recommends
Field activity, prescriptions, and account performance are read with the brand plan, not as a standalone dashboard.
AI tools
Each panel is a visual of the product. It is not a live login. PharmLens does not have a public product screen yet, so that panel is described in words.
Curated news, events, analyst commentary, and historical sales in one landscape view.
AI role-play for negotiation and sales. Scenarios cover objection handling, pricing, and access conversations.
A conversational analytics surface. A business user asks a question of commercial data instead of waiting on a new report.
Named with IntelliSight and Cintel as part of PharmSight’s proprietary toolkit. A public product screen has not been published, so this panel does not invent one.
No public screen yet
PharmLens is listed by PharmSight as part of the AI toolkit. Features beyond that are not shown here.
Try a question
Pick a question. The answer is a written sample of the kind of recommendation the practice produces. It is not generated by a live model and it is not advice for a real asset.
Sample recommendation
Start with the in-line and pipeline forecast, then test it against epidemiology and the competitive landscape. The suite for this question is Launch Excellence: one view of uptake, access risk, and the claims the field can actually defend.
Solutions
Clients
The new brand strategy was supported by analysis done by PharmSight team.
Impressed with the quick turnaround time without compromising on the quality of the deliverable.
I think we have taken a huge step forward in automating our quarterly performance analytics report.
Contact
Offices in Gurugram, Boston, and Zug. This form stays in your browser. It does not send a message to PharmSight.